Ayça Taş TUNA, Havva KOÇYİĞİT, Fatih ŞAHİN, Koray GÖK

İntraoperatif kardiyomyopati gelişen plasenta perkreta olgusunda perioperatif anemi yönetimi

Elektif cerrrahi planmalasında hastada bulunan demir eksikliği anemisinin preoperatif tedavi edilmesi morbidite ve mortalitede azalma ile ilişkili bulunmuştur. Oral demir tedavisinin yetersiz kaldığı ya da operasyon öncesi sürenin kısıtlı olduğu durumlarda İV demir tedavisi uygulanmalıdır. Gebelerde preoperatif dönemde klinik semptomu olmasa bile intraoperatif ya da postoperatif dönemde peripartum kardiyomyopati (PPKMP) gelişebileceği her zaman akılda bulundurulmalıdır.Bu olgu sunumuyla plasental invazyon anomalisi bulunan, sezaryen operasyonu sırasında ani KMP gelişen, peroperatif anemi tedavisi için intravenöz demir tedavisi uyguladığımız gebe hastayı güncel literatür ışığında tartışmayı amaçladık.

Management of perioperative anemia in a case of placenta percreata who had intraoperative cardiomyopathy

Preoperative treatment of iron deficiency anemia was associated with a decrease in morbidity and mortality. IV iron therapy should be used in cases where oral iron therapy is insufficient or the time before operation is limited. It should always be kept in mind that pregnant women can develop peripartum cardiomyopathy (PPCMP) in the intraoperative or postoperative period, even if they do not have clinical symptoms in the preoperative period. With this case report, we aimed to discuss the pregnant patient who has placental invasion anomaly, who developed sudden CMP during cesarean operation, and we applied intravenous iron therapy for the treatment of peroperative anemia in the light of current literature.

PDF

___

1. WHO. Iron deficiency anaemia : assessment, prevention and control : a guide for programme managers. In: Development NfHa ed. Geneva: World Health Organization; 2001
2. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2011(10):CD003094.
3. Muñoz M, Acheson AG, Auerbach M et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233-47.
4. Jose A, Mahey R, Sharma JB et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC Pregnancy Childbirth 2019; 19: 54.
5. Özterlemez NT, Işık G, İnan G, Günaydın B. Aritmi ablasyon öyküsü olan gebenin spinal anestezi eşliğinde sezaryenle doğumunda anemi yönetimi. Turk J Clin Lab 2020; 2: 85-88. 6. Marsoosi V, Ghotbizadeh F, Hashemi N, Molaei B. Development of a scoring system for prediction of placenta accreta and determine the accuracy of its results. J Matern Fetal Neonatal Med 2020; 33: 1824-30.
7. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999; 94: 311-6
8. Zagelbaum NK, Bhinder J, Gupta CA, Frishman WH, Aronow WS. Peripartum Cardiomyopathy Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology, and Treatment Options. Cardiol Rev 2020; 28: 148-55.
9. Unyime S Ituk 1, Ashraf S Habib, Carrie M Polin, Terrence K Allen. Anesthetic Management and Outcomes of Parturients With Dilated Cardiomyopathy in an Academic Centre. Can J Anaesth 2015; 62: 278-88.
10. Shannon-Cain J, Hunt E, Cain BS. Multidisciplinary management of peripartum cardiomyopathy during repeat caesarean delivery: A case report. AANA J 2008; 76: 443-7.